This blog site has been archived

Caffeine and Pregnancy: Why Current Guidelines Must Change!

This Spotlight Blog relates to the following article in BMJ Evidence-Based Medicine:
“Maternal Caffeine Consumption and Pregnancy Outcomes: A Narrative Review with Implications for Advice to Mothers and Mothers-To-Be”
(ID No.: bmjebm-2020-111432.R2)

Blog entry written on: ‘Maternal Caffeine Consumption and Pregnancy Outcomes: A Narrative Review with Implications for Advice to Mothers and Mothers-To-Be’ (bmjebm-2020-111406), with the author(s) listed below.

Authors: Jack E. James

Caffeine is the most widely consumed psychoactive substance in history, and surveys indicate that consumers include the majority of pregnant women. However, knowledge of caffeine pharmacology suggests high biological plausibility for potential fetal harm from maternal consumption, and observational studies provide extensive direct evidence of real harm. No fewer than 14 meta-analyses published in the past two decades unanimously report significant caffeine-related increased risk of harm. Among both observational studies and meta-analyses, there are frequent reports of significant dose-response associations suggestive of causation, and frequent reports of no threshold of consumption below which associations are absent. Perversely, current guidelines, including those issued by ACOG, the DGAC, EFSA, and the NHS, speak of “safe” levels, despite such claims being overwhelmingly inconsistent with the cumulative scientific evidence.

As early as 1980, the United States Food and Drug Administration (FDA) responded to findings of caffeine-induced teratogenic effects in rodents by issuing a warning advising pregnant women to restrict or abstain from the drug. That warning elicited a swift response from the International Life Sciences Institute (ILSI), an industry-founded global alliance of food, food additive, and agrochemical companies. Authoritative international sources have long deemed ILSI, headquartered in Washington, DC, a major threat to public health policy worldwide. Through affiliations spanning many years with the National Coffee Association, the American Beverage Association, and others, ILSI has sponsored the publication of articles depicting caffeine as a benign substance posing little or no threat to fetal health and development. Spurious conclusions have been a recurring feature of industry-affiliated commentary, which has promulgated a deception by conflating the concepts of association and causation, using legitimate questions about causation to make false claims about absence of evidence of association.

The main threats to causal inference of harm from maternal caffeine consumption are possible misclassification of exposure and outcome variables, and potential confounding from extraneous variables. However, contrary to ILSI-affiliated representations of the research literature, caffeine and pregnancy as a field of research is noteworthy for the frequent use of objective measurement (e.g., biomarkers of caffeine exposure and clinically-confirmed outcomes) to minimise risk of misclassification, and the effort invested in searching for and controlling potential confounders. The accepted main potential confounders are possible recall bias, maternal cigarette smoking, and pregnancy symptoms (e.g., nausea and vomiting).

Notably, recall bias does not present a sustainable threat to casual inference for the reason that research has largely consisted of prospective cohort studies in which measurement of caffeine exposure preceded knowledge of pregnancy outcomes. Similarly, not only has prospective measurement shown cigarette smoking to be an unlikely source of serious confounding, smoking has been conclusively disconfirmed as a confounder by frequent reports of significant caffeine-related negative pregnancy outcomes in nonsmokers and never smokers. Pregnancy symptoms are a plausible source of confounding, because their occurrence often prompts a spontaneous reduction in caffeine intake while also being a predictor of healthy pregnancy outcomes. However, diverse studies spanning nearly three decades have repeatedly disconfirmed pregnancy symptoms as a source of confounding. Again, disconfirmation has been decisive in the many studies in which potential confounding was controlled by measuring pregnancy symptoms and caffeine consumption prospectively before any knowledge of subsequent pregnancy outcomes.

In summary, an extensive body of scientific evidence from original observational studies and meta-analyses provides persuasive confirmation of increased risk from maternal caffeine consumption for at least five major negative outcomes: miscarriage, stillbirth, lower birth weight and/or small for gestational age, childhood acute leukemia, and childhood overweight and obesity. The implications are clear. Pregnant women and women contemplating pregnancy should be advised to avoid caffeine.

Author: Jack James

Short bio: Jack James, PhD, has served as Professor of Psychology at several universities in Australia and Europe. He is currently Professor of Psychology at Reykjavík University, Iceland.

COI Statement: Professor James has no conflicts of interest relevant to the topic.


The views and opinions expressed on this site are solely those of the original authors. They do not necessarily represent the views of the BMJ and should not be used to replace medical advice. All information on this blog is for general information, is not peer-reviewed, requires checking with original sources and should not be used to make any decisions about healthcare. No responsibility for its accuracy and correctness is assumed by us, and we disclaim all liability and responsibility arising from any reliance placed on such commentary or content by any user or visitor to the Website, or by anyone who may be informed of any of its content. Any reliance you place on the material posted on this site is therefore strictly at your own risk.

(Visited 1,213 times, 1 visits today)